BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 18838179)

  • 21. The role of oxidative stress in the pathogenesis of Alzheimer's disease.
    Filipcik P; Cente M; Ferencik M; Hulin I; Novak M
    Bratisl Lek Listy; 2006; 107(9-10):384-94. PubMed ID: 17262991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress signalling in Alzheimer's disease.
    Zhu X; Raina AK; Lee HG; Casadesus G; Smith MA; Perry G
    Brain Res; 2004 Mar; 1000(1-2):32-9. PubMed ID: 15053949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E and other antioxidants in neuroprotection.
    Behl C
    Int J Vitam Nutr Res; 1999 May; 69(3):213-9. PubMed ID: 10389030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents.
    Darvesh AS; Carroll RT; Bishayee A; Geldenhuys WJ; Van der Schyf CJ
    Expert Rev Neurother; 2010 May; 10(5):729-45. PubMed ID: 20420493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition.
    Steele M; Stuchbury G; Münch G
    Exp Gerontol; 2007; 42(1-2):28-36. PubMed ID: 16839733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E and other endogenous antioxidants in the central nervous system.
    Vatassery GT
    Geriatrics; 1998 Sep; 53 Suppl 1():S25-7. PubMed ID: 9745632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease.
    Greilberger J; Koidl C; Greilberger M; Lamprecht M; Schroecksnadel K; Leblhuber F; Fuchs D; Oettl K
    Free Radic Res; 2008 Jul; 42(7):633-8. PubMed ID: 18654878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
    Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
    Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain.
    Butterfield DA
    Brain Res; 2004 Mar; 1000(1-2):1-7. PubMed ID: 15053946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment.
    Frölich L; Riederer P
    Arzneimittelforschung; 1995 Mar; 45(3A):443-6. PubMed ID: 7763342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence.
    Ancelin ML; Christen Y; Ritchie K
    Dement Geriatr Cogn Disord; 2007; 24(1):1-19. PubMed ID: 17495472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.
    Cornett CR; Markesbery WR; Ehmann WD
    Neurotoxicology; 1998 Jun; 19(3):339-45. PubMed ID: 9621340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alzheimer's disease and oxidative stress].
    Yu D; Wei C; Bao Y; An L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1142-4, 1148. PubMed ID: 17121373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Could intake of vitamins C and E inhibit development of Alzheimer dementia?].
    Landmark K
    Tidsskr Nor Laegeforen; 2006 Jan; 126(2):159-61. PubMed ID: 16415937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary vitamin E, brain redox status and expression of Alzheimer's disease-relevant genes in rats.
    Gaedicke S; Zhang X; Huebbe P; Boesch-Saadatmandi C; Lou Y; Wiswedel I; Gardemann A; Frank J; Rimbach G
    Br J Nutr; 2009 Aug; 102(3):398-406. PubMed ID: 19173769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine and Alzheimer's disease: a modifiable risk?
    Dwyer BE; Raina AK; Perry G; Smith MA
    Free Radic Biol Med; 2004 Jun; 36(11):1471-5. PubMed ID: 15135184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mercury and Alzheimer's disease].
    Mutter J; Naumann J; Schneider R; Walach H
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):528-38. PubMed ID: 17628833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A "protease activation cascade" in the pathogenesis of Alzheimer's disease.
    Nixon RA
    Ann N Y Acad Sci; 2000; 924():117-31. PubMed ID: 11193788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.